The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict McKesson's revenues will increase 1.0% and EPS will grow 10.0%.
The average estimate for revenue is $32.01 billion. On the bottom line, the average EPS estimate is $2.30.
Last quarter, McKesson reported revenue of $31.19 billion. GAAP reported sales were 1.1% higher than the prior-year quarter's $30.84 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.41. GAAP EPS of $1.24 for Q3 were 3.3% higher than the prior-year quarter's $1.20 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 5.3%, 10 basis points better than the prior-year quarter. Operating margin was 1.7%, 10 basis points worse than the prior-year quarter. Net margin was 1.0%, much about the same as the prior-year quarter.
The full year's average estimate for revenue is $123.73 billion. The average EPS estimate is $7.20.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 616 members out of 644 rating the stock outperform, and 28 members rating it underperform. Among 219 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 212 give McKesson a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on McKesson is outperform, with an average price target of $104.23.
Is McKesson the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add McKesson to My Watchlist.